Skip to Main Content

Author Details

Stephen Raffanti
Vanderbilt University Medical Center
1983
73
27
PMIDPaper TitleJournal TitlePublished Year
36726547Sex and Race Disparities in Mortality and Years of Potential Life Lost Among People With HIV: A 21-Year Observational Cohort Study.Open Forum Infect Dis2022
33588614Practice Transformation in HIV Primary Care: Perspectives of Coaches and Champions in the Southeast United States.J Prim Care Community Health2021
31100116Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy.Clin Infect Dis2020
31433360Adverse Childhood Event Scores Associated With Likelihood of Missing Appointments and Unsuppressed HIV in a Southeastern U.S. Urban Clinic Sample.J Assoc Nurses AIDS Care2019
31407605CD4/CD8 Ratio and CD4 Nadir Predict Mortality Following Noncommunicable Disease Diagnosis in Adults Living with HIV.AIDS Res Hum Retroviruses2019
29678121The relationship between adverse neighborhood socioeconomic context and HIV continuum of care outcomes in a diverse HIV clinic cohort in the Southern United States.AIDS Care2018
28825943Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens.J Acquir Immune Defic Syndr2017
28462622Trends in HIV Continuum of Care Outcomes over Ten Years of Follow-Up at a Large HIV Primary Medical Home in the Southeastern United States.AIDS Res Hum Retroviruses2017
28508238Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV).Infection2017
28560901New Faces of HIV Infection: Age, Race, and Timing of Entry into HIV Care in the Southeastern United States.J Int Assoc Provid AIDS Care2017
26959354CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy.AIDS2016
25746288Risk Prediction Tool for Medical Appointment Attendance Among HIV-Infected Persons with Unsuppressed Viremia.AIDS Patient Care STDS2015
20929395Tenofovir (TDF)-selected or abacavir (ABC)-selected low-frequency HIV type 1 subpopulations during failure with persistent viremia as detected by ultradeep pyrosequencing.AIDS Res Hum Retroviruses2011
21423024Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?J Acquir Immune Defic Syndr2011
19243231Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPs.AIDS Educ Prev2009
19763810Psychosocial characteristics and sexual behaviors of people in care for HIV infection: an examination of men who have sex with men, heterosexual men and women.AIDS Behav2009
19742315Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.PLoS One2009
19076107Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department HIV Testing Consortium.Acad Emerg Med2009
19108987Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators.J Clin Epidemiol2009
19220139Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.J Infect Dis2009
19275796Potentially preventable tuberculosis among HIV-infected persons in the era of highly active antiretroviral treatment.Int J Tuberc Lung Dis2009
18627280Implementation and evaluation of a clinic-based behavioral intervention: positive steps for patients with HIV.AIDS Patient Care STDS2008
19110909Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors.J Natl Med Assoc2008
18922071Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures.Clin Infect Dis2008
17205482Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.J Infect Dis2007
17763327Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.J Infect Dis2007
16912956Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity.Clin Infect Dis2006
16818932Time's up.Ann Intern Med2006
15735444Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons.J Acquir Immune Defic Syndr2005
16084183Estimating the proportion of patients infected with HIV who will die of comorbid diseases.Am J Med2005
16107946CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.J Infect Dis2005
15319674Effect of persistent moderate viremia on disease progression during HIV therapy.J Acquir Immune Defic Syndr2004
12545146Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapy.Clin Pharmacol Ther2003
14638961Two phases of HIV RNA decay in CSF during initial days of multidrug therapy.Neurology2003
14527105Improvements in access to care for HIV and AIDS in a statewide Medicaid managed care system.Am J Manag Care2003
14526200Implications of T-cell P-glycoprotein activity during HIV-1 infection and its therapy.J Acquir Immune Defic Syndr2003
14689356Oxidant stress is increased during treatment of human immunodeficiency virus infection.Clin Infect Dis2003
12646817Fulminant Kaposi's sarcoma without mucocutaneous disease.AIDS2003
12821458Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.Antimicrob Agents Chemother2003
11176271Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort.J Acquir Immune Defic Syndr2001
11522180Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.AIDS Res Hum Retroviruses2001
11061576Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection.Clin Pharmacol Ther2000
11590500Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.HIV Clin Trials2000
11054262Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma.AIDS Res Hum Retroviruses2000
10433568Factors that predict incomplete virological response to protease inhibitor-based antiretroviral therapy.Clin Infect Dis1999
9717676Randomized, double-blind, placebo-controlled trial of the immune modulator WF10 in patients with advanced AIDS.Infection1998
9792401Acute non-lymphoblastic leukemia with an unusual chromosomal abnormality in a patient with advanced AIDS.AIDS1998
7561207Impaired hepatic protein synthesis in AIDS patients with low vitamin A levels.J Infect Dis1995
7986133Rapidly progressing nodule in a patient with the acquired immunodeficiency syndrome. Primary cutaneous B-cell lymphoma.Arch Dermatol1994
8011813Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses.Clin Infect Dis1994
  • 1 - 50 of 73

Recommended Authors

Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 1
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 3
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 1
Harvard School of Public Health
Career Start Year 1989
Number of shared co-authors 7
La Paz University Hospital
Career Start Year 1988
Number of shared co-authors 1
University Medical Center Utrecht
Career Start Year 1988
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 5
University of Cincinnati
Career Start Year 1988
Number of shared co-authors 5
University of California san francisco
Career Start Year 1988
Number of shared co-authors 6
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 3
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 6
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 0
University of Washington
Career Start Year 1984
Number of shared co-authors 6
Perelman School of Medicine, the University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 2
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 7
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 1
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 3
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 11
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 1
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1979
Number of shared co-authors 11
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 1
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 4
Institute for Global Health Sciences, University of California san francisco
Career Start Year 1977
Number of shared co-authors 5
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 2
University of California San Diego
Career Start Year 1975
Number of shared co-authors 3
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 2
University of Alabama at Birmingham
Career Start Year 1972
Number of shared co-authors 0
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 5
Wistar Institute
Career Start Year 1958
Number of shared co-authors 0

Collaborators

Vanderbilt University Medical Center
Co-authored papers 13
Vanderbilt University Medical Center
Co-authored papers 11
Co-authored papers 5
University of Colorado School of Medicine
Co-authored papers 3
VA Connecticut Healthcare System
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Albany Medical College
Co-authored papers 1
School of Public Health, University of Pittsburgh
Co-authored papers 1
Co-authored papers 1
London School of Hygiene & Tropical Medicine
Co-authored papers 1
American Hospital Association.
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Duke University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Rutgers New Jersey Medical School
Co-authored papers 1
Graduate School of Public Health, University of Pittsburgh
Co-authored papers 1
Emory University
Co-authored papers 1
Johns Hopkins
Co-authored papers 1
The University of Alabama at Birmingham
Co-authored papers 1
7 George Washington University
Co-authored papers 1
Tufts University School of Medicine, MA Baystate Medical Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1
Medical University of South Carolina
Co-authored papers 1